Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 8/20 | 0.55 |
| ▸ | MAOA | P21397 | 3/20 | 0.55 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.47 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29098086 | 1.00 | MAOB (0.55) | MAOBMAOASRD5A1HRH3MCHR1 | |
| Hydrochloric Acid SCHEMBL30199460 | 0.99 | MAOB (0.54) | MAOBMAOASRD5A1HRH3MCHR1 | |
| Hydrochloric Acid SCHEMBL29098075 | 0.99 | MAOB (0.54) | MAOBMAOASRD5A1HRH3MCHR1 | |
| SCHEMBL27946188 | 0.87 | HRH3 (0.47) | MAOBMAOAHRH3 | |
| SCHEMBL30198766 | 0.86 | MAOB (0.54) | MAOBMAOAS1PR1 | |
| SCHEMBL29098003 | 0.86 | MAOB (0.54) | MAOBMAOAS1PR1 | |
| SCHEMBL29097941 | 0.85 | MAOB (0.52) | MAOBMAOAHRH3 | |
| SCHEMBL30199270 | 0.85 | MAOB (0.52) | MAOBMAOAHRH3 | |
| SCHEMBL29097902 | 0.83 | PNMT (0.58) | MAOBMAOAHRH3 | |
| SCHEMBL3876596 | 0.83 | PNMT (0.58) | MAOBMAOASRD5A1HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115594669-B | Parallel ring derivative and preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-115594669-A | Fused ring derivative and preparation method and medical application thereof | 深圳信立泰药业股份有限公司（CN） | 2023-01-13 | — | — | CN | disclosed |